H2A.X phosphorylation elisa kit CY-1143
Ended Awarded
- Contract number
- HHSN26100001
- Awardee
-
MBL International Corporation UEI J9RMC85RENE5
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $16,856
Award facts
- Contract value 100% obligated
- $16,855.72 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- Not on record
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Fixed Price with Economic Price Adjustment
- Place of performance
- Bethesda, MD 20892, USA
Award details come from SAM.gov/FPDS.
Quick answers
Who was awarded contract HHSN26100001?
HHSN26100001 was awarded to MBL International Corporation by National Cancer Institute (National Institutes of Health) on December 3, 2010.
How much is contract HHSN26100001 worth?
The government has obligated $16,856 on HHSN26100001.
Is contract HHSN26100001 an order under another contract?
Yes. HHSN26100001 is a BPA call under HHSN263200000053546B, a blanket purchase agreement.
Was contract HHSN26100001 competed?
The extent of competition for HHSN26100001 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award